Gabapentin Capsule
Product Images NDC 72737-007

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 72737-007). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Stallion Laboratories Private Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (18928e86 E49f 46bd 92dd 5fc3daf8776a 01)

Chemical structure diagram of gabapentin, showing its cyclohexane ring and side chains with amino and carboxyl groups.*

FDA Label Image

Figure 1. (18928e86 E49f 46bd 92dd 5fc3daf8776a 02)

A line graph showing mean pain score over an 8-week period comparing placebo and gabapentin at 3600 mg/day. The x-axis represents weeks from baseline through week 8, and the y-axis shows mean pain score from 0 to 10. The graph includes a 4-week dose titration period followed by a 4-week fixed dose period.*

FDA Label Image

Figure 2 (18928e86 E49f 46bd 92dd 5fc3daf8776a 03)

A line graph showing mean pain score over a 7-week period including a 3-week dose titration and a 4-week fixed dose period. The graph compares placebo and gabapentin at doses of 1800 mg/day and 2400 mg/day, plotting scores from baseline through week 7.*

FDA Label Image

Figure 3 (18928e86 E49f 46bd 92dd 5fc3daf8776a 04)

A scatter plot chart depicting the percentage difference versus daily dose (mg) of Gabapentin capsules for three separate studies labeled a, b, and c. The x-axis shows daily doses from 600 to 1800 mg, and the y-axis shows differences from 2% to 22%. Data points for each study are represented with distinct square markers and labeled accordingly.*

FDA Label Image

Figure 4. (18928e86 E49f 46bd 92dd 5fc3daf8776a 05)

A scatter plot chart showing differences (%) on the y-axis versus daily dose (mg) on the x-axis for Gabapentin. Data points represent three studies labeled a, b, and c with different symbols and colors, illustrating variations in difference percentages at daily doses approximately 600, 900, 1200, and 1800 mg.*

FDA Label Image

100mg-100s (18928e86 E49f 46bd 92dd 5fc3daf8776a 06)

Label for Gabapentin Capsules, USP 100 mg by Stallion Laboratories Pvt. Ltd. The label indicates each capsule contains 100 mg of gabapentin. The package contains 100 capsules. Storage instructions are provided, along with a barcode and manufacturer details in Ahmedabad, India. The label also notes child-resistant packaging and dispensing requirements.*

FDA Label Image

300mg-100s (18928e86 E49f 46bd 92dd 5fc3daf8776a 07)

Label for Gabapentin Capsules, USP 300 mg by Stallion Laboratories Pvt. Ltd. The label states each capsule contains 300 mg of gabapentin, includes storage instructions, child-resistant packaging notice, and a quantity of 100 capsules. The label also displays the NDC 72737-006-02, manufacturer address in Gujarat, India, and a barcode.*

FDA Label Image

400mg-100s (18928e86 E49f 46bd 92dd 5fc3daf8776a 08)

Label for Gabapentin Capsules, USP 400 mg by Stallion Laboratories Pvt. Ltd., containing 100 capsules. The label includes storage instructions, child-resistant packaging notice, a barcode, and manufacturer details in Gujarat, India. It also references the medication guide URL and provides space for batch coding, expiration, and lot information.*

FDA Label Image

Image (18928e86 E49f 46bd 92dd 5fc3daf8776a 12 1)

The image shows a pharmacokinetic calculation formula used to estimate creatinine clearance (CLCr) based on age, weight, serum creatinine levels, and a correction factor for female patients. It is related to dosing considerations for Gabapentin capsules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.